Trial Profile
Phase I trial of CMX 2043 in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Mar 2010
Price :
$35
*
At a glance
- Drugs CMX 2043 (Primary)
- Indications Reperfusion injury
- Focus Adverse reactions
- Sponsors Ischemix